EntoGenetics Inc. — Form D/A
EntoGenetics Inc. of CHARLOTTE, NC, a company, filed a Form D amendment with the SEC on 2013-07-18. The offering totals $3.0M, of which $540K was reported sold. Industry: Manufacturing.
Offering
- Filed: 2013-07-18
- Form: D/A
- Accession: 0001546618-13-000001
- Industry: Manufacturing
- Exemptions: 06
- Total offering: $3.0M
- Amount sold: $540K
- Remaining: $2.5M
- Investors: 28
- Date of first sale: 2012-04-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-176727
Issuer
- Name: EntoGenetics Inc.
- CIK: 0001546618
- Entity type: Corporation
- Jurisdiction: NORTH CAROLINA
- Address: 7125 COLLETON PLACE, CHARLOTTE, NC, 28270
- Phone: 704.280.5804
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Robert Bogin | Director | Potomac, MD |
| David Brigham | Director | Charlotte, NC |
| Nicholas Rose | Director | Charlotte, NC |
| David Brigham | Executive Officer | Charlotte, NC |
| Teresa Brigham | Executive Officer | Charlotte, NC |
| Nicholas Rose | Executive Officer | Charlotte, NC |
| Teresa Brigham | Director | Charlotte, NC |
Other filings by this issuer (1)
More